Insight into the prognostic factors of chronic inflammatory demyelinating polyneuropathy

키워드

참고문헌 (36)

1. McLeod J, "Prevalence of chronic inflammatory demyelinating polyneuropathy in New South Wales, Australia", Ann Neurol, 46, pp.910~913 (1999)
2. Lunn M, "Chronic inflammatory demyelinating polyradiculoneuropathy : a prevalence study in south east England", J Neurol Neurosurg Psychiatry, 66, pp.677~680 (1999)
3. Iijima M, "Prevalence and incidence rates of chronic inflammatory demyelinating polyneuropathy in the Japanese population", J Neurol Neurosurg Psychiatry, 79, pp.1040~1043 (2008)
4. Rajabally YA, "Epidemiologic variability of chronic inflammatory demyelinating polyneuropathy with different diagnostic criteria : study of a UK population", Muscle Nerve, 39, pp.432~438 (2009)
5. Laughlin R, "Incidence and prevalence of CIDP and the association of diabetes mellitus", Neurology, 73, pp.39~45 (2009)
6. Bouchard C, "Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy", Neurology, 52, pp.498~503 (1999)
7. Kuwabara S, "Long term prognosis of chronic inflammatory demyelinating polyneuropathy : a five year follow up of 38 cases", J Neurol Neurosurg Psychiatry, 77, pp.66~70 (2006)
8. Viala K, "A current view of the diagnosis, clinical variants, response to treatment and prognosis of chronic inflammatory demyelinating polyradiculoneuropathy", J Peripher Nerv Syst, 15, pp.50~56 (2010)
9. Rotta FT, "The spectrum of chronic inflammatory demyelinating polyneuropathy", J Neurol Sci, 173, pp.129~139 (2000)
10. Joint Task Force of the EFNS and the PNS, "European Federation of Neurological Societies", Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy:report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society–First Revision, 2010, pp.15, 1~9
11. Kuwabara S, "Different electrophysiological profiles and treatment response in ‘typical’ and ‘atypical’ chronic inflammatory demyelinating polyneuropathy", J Neurol Neurosurg Psychiatry, 86, pp.1054~1059 (2015)
12. Fargeot G, "Comparison of Lewis–Sumner syndrome with chronic inflammatory demyelinating polyradiculoneuropathy patients in a tertiary care centre", Eur J Neurol, 27, pp.522~528 (2020)
13. Doneddu PE, "Atypical CIDP: diagnostic criteria, progression and treatment response. Data from the Italian CIDP database", J Neurol Neurosurg Psychiatry, 90, pp.125~132 (2019)
14. Katz J, "Distal acquired demyelinating symmetric neuropathy", Neurology, 54, pp.615~620 (2000)
15. Larue S, "Non-anti-MAG DADS neuropathy as a variant of CIDP: clinical, electrophysiological, laboratory features and response to treatment in 10 cases", Eur J Neurol, 18, pp.899~905 (2011)
16. Mygland Å, "Chronic acquired demyelinating symmetric polyneuropathy classified by pattern of weakness", Arch Neurol, 60, pp.260~264 (2003)
17. Staudt M, "Differences in peripheral myelin antigen-specific T cell responses and T memory subsets in atypical versus typical CIDP", BMC Neurol, 17, pp.81~ (2017)
18. Kuwabara S, "Chronic inflammatory demyelinating polyneuropathy : the spectrum and immunopathogenesis deciphered by electrophysiology and neuroimaging", Clin Exp Neuroimmunol, 9, pp.47~53 (2018)
19. Abraham A, "Treatment responsiveness in CIDP patients with diabetes is associated with higher degrees of demyelination", PLoS one, 10, pp.e0139674~ (2015)
20. Chin RL, "Follow-up nerve conduction studies in CIDP after treatment with IGIV-C : comparison of patients with and without subsequent relapse", Muscle Nerve, 52, pp.498~502 (2015)
21. Iijima M, "Clinical and electrophysiologic correlates of IVIg responsiveness in CIDP", Neurology, 64, pp.1471~1475 (2005)
22. Baek SH, "Electrodiagnostic data-driven clustering identifies a prognostically different subgroup of patients with chronic inflammatory demyelinating polyneuropathy", J Neurol Neurosurg Psychiatry, 90, pp.674~680 (2019)
23. Bril V, "Electrophysiologic correlations with clinical outcomes in CIDP", Muscle Nerve, 42, pp.492~497 (2010)
24. Rajabally Y, "Distribution, clinical correlates and significance of axonal loss and demyelination in chronic inflammatory demyelinating polyneuropathy", Eur J Neurol, 18, pp.293~299 (2011)
25. Koike H, "Paranodal dissection in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin-155 and anti-contactin-1antibodies", J Neurol Neurosurg Psychiatry, 88, pp.465~473 (2017)
26. Devaux JJ, "Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy", Neurology, 86, pp.800~807 (2016)
27. Ng JKM, "Neurofascin as a target for autoantibodies in peripheral neuropathies", Neurology, 79, pp.2241~2248 (2012)
28. Querol L, "Antibodies to contactin-1in chronic inflammatory demyelinating polyneuropathy", Ann Neurol, 73, pp.370~380 (2013)
29. Garg N, "Neurofascin-155 IGG4 neuropathy: pathophysiological insights, spectrum of clinical severity and response to treatment", Muscle Nerve, 57, pp.848~851 (2018)
30. Kadoya M, "IgG4 anti-neurofascin155 antibodies in chronic inflammatory demyelinating polyradiculoneuropathy : clinical significance and diagnostic utility of a conventional assay", J Neuroimmunol, 301, pp.16~22 (2016)
31. Ogata H, "Characterization of IgG4 anti-neurofascin 155 antibody-positive polyneuropathy", Ann Clin Transl Neurol, 2, pp.960~971 (2015)
32. Querol L, "Antibodies against peripheral nerve antigens in chronic inflammatory demyelinating polyradiculoneuropathy", Sci Rep, 7, pp.14411~ (2017)
33. Miura Y, "Contactin 1 IgG4 associates to chronic inflammatory demyelinating polyneuropathy with sensory ataxia", Brain, 138(Pt 6), pp.1484~1491 (2015)
34. Mathey E, "Autoantibody responses to nodal and paranodal antigens in chronic inflammatory neuropathies", J Neuroimmunol, 309, pp.41~46 (2017)
35. Doppler K, "Auto-antibodies to contactin-associated protein 1(Caspr)in two patients with painful inflammatory neuropathy", Brain, 139(Pt 10), pp.2617~2630 (2016)
36. Querol L, "Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins", Neurol Neuroimmunol Neuroinflamm, 2, pp.e149~ (2015)

관련 논문AI추천